Understanding, predicting and achieving liver transplant tolerance: from bench to bedside
- 30 November 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Gastroenterology & Hepatology
- Vol. 17 (12), 719-739
- https://doi.org/10.1038/s41575-020-0334-4
Abstract
In the past 40 years, liver transplantation has evolved from a high-risk procedure to one that offers high success rates for reversal of liver dysfunction and excellent patient and graft survival. The liver is the most tolerogenic of transplanted organs; indeed, immunosuppressive therapy can be completely withdrawn without rejection of the graft in carefully selected, stable long-term liver recipients. However, in other recipients, chronic allograft injury, late graft failure and the adverse effects of anti-rejection therapy remain important obstacles to improved success. The liver has a unique composition of parenchymal and immune cells that regulate innate and adaptive immunity and that can promote antigen-specific tolerance. Although the mechanisms underlying liver transplant tolerance are not well understood, important insights have been gained into how the local microenvironment, hepatic immune cells and specific molecular pathways can promote donor-specific tolerance. These insights provide a basis for the identification of potential clinical biomarkers that might correlate with tolerance or rejection and for the development of novel therapeutic targets. Innovative approaches aimed at promoting immunosuppressive drug minimization or withdrawal include the adoptive transfer of donor-derived or recipient-derived regulatory immune cells to promote liver transplant tolerance. In this Review, we summarize and discuss these developments and their implications for liver transplantation. In this Review, Thomson et al. describe the immunobiology underlying liver graft tolerance and failure, and discuss therapeutic approaches for minimization or withdrawal of anti-rejection immunosuppressive drug therapy post transplantation.This publication has 298 references indexed in Scilit:
- Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regressionHepatology, 2011
- Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantationHepatology, 2011
- Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injuryHepatology, 2009
- Reduced serum hepcidin levels in patients with chronic hepatitis CJournal of Hepatology, 2009
- A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejectionMicrosurgery, 2009
- Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanismHepatology, 2009
- Indirect action of tumor necrosis factor-alpha in liver injury during the CD8+ T cell response to an adeno-associated virus vector in miceHepatology, 2009
- Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cellsJournal of Hepatology, 2008
- Plasmacytoid Dendritic Cells Mediate Oral ToleranceImmunity, 2008
- Mechanism of T cell tolerance induction by murine hepatic Kupffer cellsHepatology, 2008